APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Excipients for Oral Solid Dosage Forms

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Research Report 2026

Report ID 174024790523 December 2025132 pages

Choose your research edition.

Industry ResearchPharmaceutical Excipients for Oral Solid Dosage Forms Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Excipients for Oral Solid Dosage Forms market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pharmaceutical Excipients for Oral Solid Dosage Forms is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pharmaceutical Excipients for Oral Solid Dosage Forms is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Excipients for Oral Solid Dosage Forms is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms include Ashland, Associated British Foods, BASF, Croda International, Dow, Evonik, JRS Pharma, Lubrizol and Mitsubishi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pharmaceutical Excipients for Oral Solid Dosage Forms market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Company

Ashland

Associated British Foods

BASF

Croda International

Dow

Evonik

JRS Pharma

Lubrizol

Mitsubishi

Roquette

Shin-Etsu

Südzucker AG

Hunan Er-Kang Pharmaceutical Co., Ltd.

Tianjin Chasesun Pharmaceutical Co., Ltd.

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

Sunrise Manufacture Group Co., Ltd.

Nanjing Well Pharmaceutical Group Co.,Ltd.

Xiwang Group

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Type

Fillers

Lubricants

Binders

Disintegrants

Coating Materials

Other

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Application

Tablets

Granules and Powders

Capsules

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Excipients for Oral Solid Dosage Forms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Excipients for Oral Solid Dosage Forms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Excipients for Oral Solid Dosage Forms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pharmaceutical Excipients for Oral Solid Dosage Forms manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pharmaceutical Excipients for Oral Solid Dosage Forms by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pharmaceutical Excipients for Oral Solid Dosage Forms in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t) of Manufacturers (2021-2026) Table 7. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue of Manufacturers (2021-2026) Table 9. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pharmaceutical Excipients for Oral Solid Dosage Forms Average Price (USD/t) of Manufacturers (2021-2026) Table 11. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms, Product Type & Application Table 14. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pharmaceutical Excipients for Oral Solid Dosage Forms by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Ashland Company Information Table 19. Ashland Business Overview Table 20. Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 21. Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 22. Ashland Recent Developments Table 23. Associated British Foods Company Information Table 24. Associated British Foods Business Overview Table 25. Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 26. Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 27. Associated British Foods Recent Developments Table 28. BASF Company Information Table 29. BASF Business Overview Table 30. BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 31. BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 32. BASF Recent Developments Table 33. Croda International Company Information Table 34. Croda International Business Overview Table 35. Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 36. Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 37. Croda International Recent Developments Table 38. Dow Company Information Table 39. Dow Business Overview Table 40. Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 41. Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 42. Dow Recent Developments Table 43. Evonik Company Information Table 44. Evonik Business Overview Table 45. Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 46. Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 47. Evonik Recent Developments Table 48. JRS Pharma Company Information Table 49. JRS Pharma Business Overview Table 50. JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 51. JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 52. JRS Pharma Recent Developments Table 53. Lubrizol Company Information Table 54. Lubrizol Business Overview Table 55. Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 56. Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 57. Lubrizol Recent Developments Table 58. Mitsubishi Company Information Table 59. Mitsubishi Business Overview Table 60. Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 61. Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 62. Mitsubishi Recent Developments Table 63. Roquette Company Information Table 64. Roquette Business Overview Table 65. Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 66. Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 67. Roquette Recent Developments Table 68. Shin-Etsu Company Information Table 69. Shin-Etsu Business Overview Table 70. Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 71. Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 72. Shin-Etsu Recent Developments Table 73. Südzucker AG Company Information Table 74. Südzucker AG Business Overview Table 75. Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 77. Südzucker AG Recent Developments Table 78. Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information Table 79. Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview Table 80. Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 82. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments Table 83. Tianjin Chasesun Pharmaceutical Co., Ltd. Company Information Table 84. Tianjin Chasesun Pharmaceutical Co., Ltd. Business Overview Table 85. Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 87. Tianjin Chasesun Pharmaceutical Co., Ltd. Recent Developments Table 88. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Company Information Table 89. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Business Overview Table 90. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 92. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Recent Developments Table 93. Sunrise Manufacture Group Co., Ltd. Company Information Table 94. Sunrise Manufacture Group Co., Ltd. Business Overview Table 95. Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 97. Sunrise Manufacture Group Co., Ltd. Recent Developments Table 98. Nanjing Well Pharmaceutical Group Co.,Ltd. Company Information Table 99. Nanjing Well Pharmaceutical Group Co.,Ltd. Business Overview Table 100. Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 102. Nanjing Well Pharmaceutical Group Co.,Ltd. Recent Developments Table 103. Xiwang Group Company Information Table 104. Xiwang Group Business Overview Table 105. Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 107. Xiwang Group Recent Developments Table 108. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2021-2026) & (t) Table 110. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Region (2021-2026) Table 111. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2027-2032) & (t) Table 112. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Region (2027-2032) Table 113. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region (2021-2026) Table 115. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region (2027-2032) Table 117. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 119. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 120. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 124. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 125. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 129. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 130. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 134. South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 135. South America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 139. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 140. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 143. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (t) Table 144. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2021-2026) Table 145. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2027-2032) Table 146. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2021-2026) Table 149. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2027-2032) Table 150. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2021-2026) & (USD/t) Table 151. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2027-2032) & (USD/t) Table 152. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 153. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (t) Table 154. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2021-2026) Table 155. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2027-2032) Table 156. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2021-2026) Table 159. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2027-2032) Table 160. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2021-2026) & (USD/t) Table 161. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2027-2032) & (USD/t) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Pharmaceutical Excipients for Oral Solid Dosage Forms Distributors List Table 165. Pharmaceutical Excipients for Oral Solid Dosage Forms Customers List Table 166. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Trends Table 167. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Drivers Table 168. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Image Figure 5. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size (2021-2032) & (US$ Million) Figure 7. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (2021-2032) & (t) Figure 8. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Average Price (USD/t) & (2021-2032) Figure 9. Fillers Product Image Figure 10. Lubricants Product Image Figure 11. Binders Product Image Figure 12. Disintegrants Product Image Figure 13. Coating Materials Product Image Figure 14. Other Product Image Figure 15. Tablets Product Image Figure 16. Granules and Powders Product Image Figure 17. Capsules Product Image Figure 18. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Pharmaceutical Excipients for Oral Solid Dosage Forms Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region in 2025 Figure 24. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region in 2025 Figure 25. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country in 2025 Figure 26. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2032) Figure 27. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Country (2021-2032) Figure 28. United States Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country in 2025 Figure 32. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2032) Figure 33. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Country (2021-2032) Figure 34. Germany Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country in 2025 Figure 45. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Country (2021-2032) Figure 47. China Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country in 2025 Figure 56. South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2032) Figure 57. South America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Country (2021-2032) Figure 58. Brazil Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country in 2025 Figure 62. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Country (2021-2032) Figure 64. Egypt Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2021-2032) Figure 70. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2021-2032) Figure 71. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price (USD/t) by Type (2021-2032) Figure 72. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2021-2032) Figure 73. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2021-2032) Figure 74. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price (USD/t) by Application (2021-2032) Figure 75. Pharmaceutical Excipients for Oral Solid Dosage Forms Value Chain Figure 76. Pharmaceutical Excipients for Oral Solid Dosage Forms Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Opportunities and Challenges

Scope & coverage.

Types
  • Fillers
  • Lubricants
  • Binders
  • Disintegrants
  • Coating Materials
  • Other
Applications
  • Tablets
  • Granules and Powders
  • Capsules
Companies covered
  • Ashland
  • Associated British Foods
  • BASF
  • Croda International
  • Dow
  • Evonik
  • JRS Pharma
  • Lubrizol
  • Mitsubishi
  • Roquette
  • Shin-Etsu
  • Südzucker AG
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Tianjin Chasesun Pharmaceutical Co., Ltd.
  • Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
  • Sunrise Manufacture Group Co., Ltd.
  • Nanjing Well Pharmaceutical Group Co.,Ltd.
  • Xiwang Group

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size (2021-2032)
  4. 2.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (2021-2032)
  5. 2.2.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Average Price (2021-2032)
  6. 2.3 Pharmaceutical Excipients for Oral Solid Dosage Forms by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Fillers
  9. 2.3.3 Lubricants
  10. 2.3.4 Binders
  11. 2.3.5 Disintegrants
  12. 2.3.6 Coating Materials
  13. 2.3.7 Other
  14. 2.4 Pharmaceutical Excipients for Oral Solid Dosage Forms by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Tablets
  17. 2.4.3 Granules and Powders
  18. 2.4.4 Capsules
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t) of Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms, Product Type & Application
  8. 3.8 Global Manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms, Established Date
  9. 3.9 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Ashland
  2. 4.1.1 Ashland Company Information
  3. 4.1.2 Ashland Business Overview
  4. 4.1.3 Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  6. 4.1.5 Ashland Recent Developments
  7. 4.2 Associated British Foods
  8. 4.2.1 Associated British Foods Company Information
  9. 4.2.2 Associated British Foods Business Overview
  10. 4.2.3 Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  12. 4.2.5 Associated British Foods Recent Developments
  13. 4.3 BASF
  14. 4.3.1 BASF Company Information
  15. 4.3.2 BASF Business Overview
  16. 4.3.3 BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  18. 4.3.5 BASF Recent Developments
  19. 4.4 Croda International
  20. 4.4.1 Croda International Company Information
  21. 4.4.2 Croda International Business Overview
  22. 4.4.3 Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  24. 4.4.5 Croda International Recent Developments
  25. 4.5 Dow
  26. 4.5.1 Dow Company Information
  27. 4.5.2 Dow Business Overview
  28. 4.5.3 Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  30. 4.5.5 Dow Recent Developments
  31. 4.6 Evonik
  32. 4.6.1 Evonik Company Information
  33. 4.6.2 Evonik Business Overview
  34. 4.6.3 Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  36. 4.6.5 Evonik Recent Developments
  37. 4.7 JRS Pharma
  38. 4.7.1 JRS Pharma Company Information
  39. 4.7.2 JRS Pharma Business Overview
  40. 4.7.3 JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  42. 4.7.5 JRS Pharma Recent Developments
  43. 4.8 Lubrizol
  44. 4.8.1 Lubrizol Company Information
  45. 4.8.2 Lubrizol Business Overview
  46. 4.8.3 Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  48. 4.8.5 Lubrizol Recent Developments
  49. 4.9 Mitsubishi
  50. 4.9.1 Mitsubishi Company Information
  51. 4.9.2 Mitsubishi Business Overview
  52. 4.9.3 Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  54. 4.9.5 Mitsubishi Recent Developments
  55. 4.10 Roquette
  56. 4.10.1 Roquette Company Information
  57. 4.10.2 Roquette Business Overview
  58. 4.10.3 Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  60. 4.10.5 Roquette Recent Developments
  61. 4.11 Shin-Etsu
  62. 4.11.1 Shin-Etsu Company Information
  63. 4.11.2 Shin-Etsu Business Overview
  64. 4.11.3 Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  66. 4.11.5 Shin-Etsu Recent Developments
  67. 4.12 Südzucker AG
  68. 4.12.1 Südzucker AG Company Information
  69. 4.12.2 Südzucker AG Business Overview
  70. 4.12.3 Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  72. 4.12.5 Südzucker AG Recent Developments
  73. 4.13 Hunan Er-Kang Pharmaceutical Co., Ltd.
  74. 4.13.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  78. 4.13.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Tianjin Chasesun Pharmaceutical Co., Ltd.
  80. 4.14.1 Tianjin Chasesun Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Tianjin Chasesun Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  84. 4.14.5 Tianjin Chasesun Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
  86. 4.15.1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Company Information
  87. 4.15.2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Business Overview
  88. 4.15.3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  90. 4.15.5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Recent Developments
  91. 4.16 Sunrise Manufacture Group Co., Ltd.
  92. 4.16.1 Sunrise Manufacture Group Co., Ltd. Company Information
  93. 4.16.2 Sunrise Manufacture Group Co., Ltd. Business Overview
  94. 4.16.3 Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  96. 4.16.5 Sunrise Manufacture Group Co., Ltd. Recent Developments
  97. 4.17 Nanjing Well Pharmaceutical Group Co.,Ltd.
  98. 4.17.1 Nanjing Well Pharmaceutical Group Co.,Ltd. Company Information
  99. 4.17.2 Nanjing Well Pharmaceutical Group Co.,Ltd. Business Overview
  100. 4.17.3 Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  102. 4.17.5 Nanjing Well Pharmaceutical Group Co.,Ltd. Recent Developments
  103. 4.18 Xiwang Group
  104. 4.18.1 Xiwang Group Company Information
  105. 4.18.2 Xiwang Group Business Overview
  106. 4.18.3 Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  108. 4.18.5 Xiwang Group Recent Developments
5 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Scenario by Region
  1. 5.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region: 2021-2032
  3. 5.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region: 2021-2026
  4. 5.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region: 2027-2032
  5. 5.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region: 2021-2032
  6. 5.3.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region: 2021-2026
  7. 5.3.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region: 2027-2032
  8. 5.4 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Facts & Figures by Country
  9. 5.4.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2032)
  11. 5.4.3 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Facts & Figures by Country
  16. 5.5.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2032)
  18. 5.5.3 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Facts & Figures by Country
  41. 5.7.1 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2032)
  43. 5.7.3 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032)
  2. 6.1.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032) & (t)
  3. 6.1.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2032)
  5. 6.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032)
  2. 7.1.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032) & (t)
  3. 7.1.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2032)
  5. 7.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Value Chain Analysis
  2. 8.1.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Production Mode & Process
  5. 8.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Distributors
  8. 8.2.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Customers
9 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Analyzing Market Dynamics
  1. 9.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Trends
  2. 9.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Drivers
  3. 9.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Opportunities and Challenges
  4. 9.4 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst